Lan Demets has made several key contributions to oncology, particularly in the areas of molecular biology and clinical trials. His research has helped to identify specific biomarkers that can predict cancer progression and response to treatment. This has paved the way for more personalized treatment approaches, improving outcomes for many patients.
